Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orhan Sezer

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
European Journal of Haematology|September 25, 2002
Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myelomaChristian Jakob, Ivana Zavrski, Ulrike Heider, et al.
European Journal of Haematology|February 14, 2004
Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infectionUlrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology|December 11, 2008
Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatmentUlrike Heider, Martin Kaiser, Maren Mieth, et al.
The International Journal of Biochemistry & Cell Biology|August 19, 2008
Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7Gregor Kalwitz, Michaela Endres, Katja Neumann, et al.
European Journal of Haematology|August 23, 2006
Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatmentUlrike Heider, Martin Kaiser, Christian Müller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypesRolf Kaiser, Orhan Sezer, Anja Papies, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 2008
Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinaseIvana von Metzler, Holger Krebbel, Ulrike Kuckelkorn, et al.
Anti-Cancer Drugs|May 2, 2002
Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II studyErnst Späth-Schwalbe, Catalina Lange, Isabelle Genvresse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myelomaUlrike Heider, Corinna Langelotz, Christian Jakob, et al.
Anti-Cancer Drugs|August 24, 2006
Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphomaJan Eucker, Jan Sterz, Holger Krebbel, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|September 25, 2002
Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myelomaChristian Jakob, Ivana Zavrski, Ulrike Heider, et al.
European Journal of Haematology|February 14, 2004
Treatment of refractory chronic lymphocytic leukemia with Campath-1H in combination with lamivudine in chronic hepatitis B infectionUlrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology|December 11, 2008
Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatmentUlrike Heider, Martin Kaiser, Maren Mieth, et al.
The International Journal of Biochemistry & Cell Biology|August 19, 2008
Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7Gregor Kalwitz, Michaela Endres, Katja Neumann, et al.
European Journal of Haematology|August 23, 2006
Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatmentUlrike Heider, Martin Kaiser, Christian Müller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypesRolf Kaiser, Orhan Sezer, Anja Papies, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 2008
Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinaseIvana von Metzler, Holger Krebbel, Ulrike Kuckelkorn, et al.
Anti-Cancer Drugs|May 2, 2002
Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II studyErnst Späth-Schwalbe, Catalina Lange, Isabelle Genvresse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myelomaUlrike Heider, Corinna Langelotz, Christian Jakob, et al.
Anti-Cancer Drugs|August 24, 2006
Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphomaJan Eucker, Jan Sterz, Holger Krebbel, et al.
Pageof 11